Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.
Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients. Clin Cancer Res. 2012 Sep 01; 18(17):4785-93.